Please Wait.....
Report
China Immunoassay Reagents and Devices Market
Market Report I 2025-08-01 I 350 Pages I Data Bridge Market Research
China immunoassay reagents and devices market is expected to reach USD 3.04 billion by 2032 from USD 1.88 billion in 2024, growing with a CAGR of 6.2% in the forecast period of 2025 to 2032.
Market Segmentation:
China Immunoassay Reagents and Devices Market, By Product Type (Immunoassay Reagents & Kits, Immunoassay Devices), By Platform (Chemiluminescence Immunoassays (CLIA), Enzyme Immunoassay (EIA/ELISA), Fluorescence Immunoassays (FIA), Chromatographic Immunoassays, Immunohistochemistry, Radioimmunoassays (RIA), Turbidimetric Immunoassays, Microarray Immunoassays, Counting Immunoassays, Others), By Type (Laboratory Based, Point Of Care), By Specimen Type (Blood, Urine, Saliva, Others), By Application (Infectious Diseases, Cancer Biomarkers, Endocrinology, Bone and Mineral Disorders, Cardiology, Hematology and Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, Allergy Diagnostics, Gastrology, Others), By End User (Hospitals, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Blood Banks, Research And Academic Laboratories, Ambulatory Care Centers, Nursing Homes, Home Healthcare Agencies, Others) -Industry Trends & Forecast To 2032
Overview of the Global Immunoassay reagents and devices are:
Driver
- Increasing prevalence of chronic diseases boosting demand.
Restrain
- High cost of immunoassay reagents and devices
Opportunity
- Expansion of healthcare infrastructure in emerging markets
Market Players:
The key market players for China Immunoassay reagents and devices are listed below:
- F. Hoffmann-La Roche Ltd (Switzerland)
- Siemens (Germany)
- Abbott Laboratories (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- QuidelOrtho Corporation (U.S.)
- Bio-Techne (U.S.)
- BIOM?RIEUX (France)
- DIASORIN S.P.A (Italy)
- Danaher (U.S.)
- Tosoh Bioscience LLC (Japan)
- Hipro Biotechnology Co., Ltd. (China)
- Agilent Technologies, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Sysmex (Japan)
- BD (U.S.)
- QIAGEN (Germany)
- Revvity (U.S.)
- SD Biosensor, INC (South Korea)
TABLE OF CONTENTS
1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 OVERVIEW OF CHINA IMMUNOASSAY REAGENTS AND DEVICE MARKET 17
1.4 MARKETS COVERED 19
2 MARKET SEGMENTATION 22
2.1 MARKETS COVERED 22
2.2 GEOGRAPHICAL SCOPE 23
2.3 YEARS CONSIDERED FOR THE STUDY 23
2.4 CURRENCY AND PRICING 23
2.5 DBMR TRIPOD DATA VALIDATION MODEL 24
2.6 MULTIVARIATE MODELLING 27
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 28
2.8 DBMR MARKET POSITION GRID 29
2.9 VENDOR SHARE ANALYSIS 30
2.10 MARKET END USER COVERAGE GRID 31
2.11 SECONDARY SOURCES 32
2.12 ASSUMPTIONS 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 40
5 PREMIUM INSIGHTS 41
5.1 PESTAL ANALYSIS 41
5.2 PORTER'S FIVE FORCES ANALYSIS 42
5.3 TECHNOLOGICAL ADVANCEMENTS IN THE TECHNOLOGICAL ADVANCEMENTS IN THE GLOBAL NATURAL TERPENE MARKET 43
5.4 MICRO AND MACRO ECONOMIC FACTORS 49
5.5 PENETRATION AND GROWTH PROSPECT MAPPING 50
5.6 KEY PRICING STRATEGIES 50
5.7 INTELLECTUAL PROPERTY (IP) PORTFOLIO ANALYSIS 51
5.7.1 PATENT QUALITY AND STRENGTH 51
5.7.2 AND COLLABORATIONS 51
5.8 COST STRUCTURE BREAKDOWN 52
5.8.1 IMMUNOASSAY REAGENTS 52
5.8.2 IMMUNOASSAY DEVICES (ANALYZERS): 53
?
5.9 REGULATORY COMPLIANCE 54
5.9.1 REGULATORY AUTHORITIES 54
5.9.2 REGULATORY CLASSIFICATIONS 54
5.9.2.1 CLASS I (LOW RISK) 54
5.9.2.2 CLASS II (MODERATE RISK) 54
5.9.2.3 CLASS III (HIGH RISK) 54
5.9.3 REGULATORY SUBMISSIONS 54
5.9.4 INTERNATIONAL HARMONIZATION 55
5.9.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 55
5.9.6 REGULATORY CHALLENGES AND STRATEGIES 55
5.10 OPPORTUNITY MAP ANALYSIS 56
5.11 VALUE CHAIN ANALYSIS 57
6 MARKET OVERVIEW 58
6.1 DRIVERS 60
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 60
6.1.2 RISING HEALTHCARE INVESTMENTS IN DIAGNOSTIC TECHNOLOGIES 61
6.1.3 GROWING DEMAND FOR PERSONALIZED MEDICINE AND TREATMENTS 61
6.1.4 TECHNOLOGICAL ADVANCEMENTS IN IMMUNOASSAY REAGENTS AND DEVICES 62
6.2 RESTRAINTS 64
6.2.1 FRAGMENTED MARKET WITH INTENSE LOW-COST COMPETITION CAUSING PRICING PRESSURE 64
6.2.2 STRINGENT REGULATORY APPROVAL PROCESSES FOR NEW PRODUCTS 64
6.3 OPPORTUNITIES 65
6.3.1 GROWTH IN RESEARCH AND DEVELOPMENT OF IMMUNOASSAYS 65
6.3.2 EXPANSION OF POINT-OF-CARE IMMUNOASSAY TESTING 66
6.3.3 INDUSTRY COLLABORATIONS ADVANCING IMMUNOASSAY CAPABILITIES 66
6.4 CHALLENGES 68
6.4.1 HIGH COST OF ADVANCED IMMUNOASSAY SYSTEMS AND IMPLEMENTATION 68
6.4.2 SHORTAGE OF SKILLED WORKFORCE AND TECHNICAL EXPERTISE 69
?
7 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT TYPE 70
7.1 OVERVIEW 71
7.2 IMMUNOASSAY REAGENTS & KITS 74
7.2.1 CHEMILUMINESCENCE IMMUNOASSAYS KITS AND REAGENTS 77
7.2.2 ELISA KITS AND REAGENTS 77
7.2.3 RAPID TEST KITS AND REAGENTS 77
7.2.4 IMMUNOHISTOCHEMISTRY ASSAYS KITS AND REAGENTS 77
7.2.5 BEAD-BASED IMMUNOASSAYS KITS AND REAGENTS 77
7.2.6 WESTERN BLOT KITS AND REAGENTS 77
7.2.7 ELISPOT KITS AND REAGENTS 77
7.2.8 RADIOIMMUNOASSAY KITS AND REAGENTS 77
7.2.9 MICROARRAY IMMUNOASSAYS KITS AND REAGENTS 77
7.2.10 MULTIPLEX MICROARRAY ASSAYS KITS AND REAGENTS 77
7.2.11 OTHER IMMUNOASSAY KITS AND REAGENTS 77
7.3 IMMUNOASSAY DEVICES 78
7.3.1 ANALYZERS 78
7.3.1.1 AUTOMATIC ANALYZERS 79
7.3.1.1.1 CLOSED-ENDED SYSTEMS 79
7.3.1.1.1.1 MODULAR 80
7.3.1.1.1.2 FLOOR-STANDING 80
7.3.1.1.1.3 BENCH-TOP 80
7.3.1.1.1.4 OTHERS 80
7.3.1.1.2 OPEN-ENDED SYSTEMS 80
7.3.1.1.2.1 BENCH-TOP 81
7.3.1.1.2.2 FLOOR-STANDING 81
7.3.1.1.2.3 MODULAR 81
7.3.1.1.2.4 OTHERS 81
7.3.1.2 SEMI-AUTOMATIC ANALYZERS 82
7.3.1.2.1 BENCH-TOP 83
7.3.1.2.2 FLOOR-STANDING 83
7.3.1.2.3 MODULAR 83
7.3.1.2.4 OTHERS 83
7.3.1.1 RENTAL PURCHASE 83
7.3.1.2 OUTRIGHT PURCHASE 83
7.3.1.1 BENCH-TOP 83
7.3.1.2 FLOOR-STANDING 83
7.3.1.3 MODULAR 83
7.3.1.4 OTHERS 84
?
7.3.2 ACCESSORIES AND CONSUMABLES 84
7.3.2.1 THERMAL PRINTER 84
7.3.2.2 BARCODE SCANNER 84
7.3.2.3 OTHERS 84
7.3.3 POCT DEVICES 84
7.3.3.1 BENCH-TOP 84
7.3.3.2 HANDHELD 84
8 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM 85
8.1 OVERVIEW 86
8.2 CHEMILUMINESCENCE IMMUNOASSAYS (CLIA) 90
8.3 ENZYME IMMUNOASSAY (EIA/ELISA) 91
8.3.1 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) 92
8.3.1.1 THIRD-GENERATION ELISA 92
8.3.1.2 FOURTH-GENERATION ELISA 92
8.3.1.3 SECOND-GENERATION ELISA 92
8.3.1.4 FIRST-GENERATION ELISA 92
8.3.2 ENZYME LINKED FLUORESCENT IMMUNOASSAY (ELFA) 92
8.4 FLUORESCENCE IMMUNOASSAYS (FIA) 92
8.5 CHROMATOGRAPHIC IMMUNOASSAYS 92
8.6 IMMUNOHISTOCHEMISTRY 92
8.7 RADIOIMMUNOASSAYS (RIA) 92
8.8 TURBIDIMETRIC IMMUNOASSAYS 93
8.9 MICROARRAY IMMUNOASSAYS 93
8.10 COUNTING IMMUNOASSAYS 93
8.11 OTHERS 93
9 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE 94
9.1 OVERVIEW 95
9.2 LABORATORY BASED 98
9.3 POINT OF CARE 98
10 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE 99
10.1 OVERVIEW 100
10.2 BLOOD 103
10.3 URINE 103
10.4 SALIVA 103
10.5 OTHERS 103
?
11 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION 104
11.1 OVERVIEW 105
11.2 INFECTIOUS DISEASES 110
11.2.1 IMMUNOASSAY REAGENTS & KITS 110
11.2.2 IMMUNOASSAY DEVICES 110
11.3 CANCER BIOMARKERS 111
11.3.1 CARCINO EMBRYONIC ANTIGEN (CEA) 111
11.3.1.1 IMMUNOASSAY REAGENTS & KITS 111
11.3.1.2 IMMUNOASSAY DEVICES 111
11.3.2 ALPHA-FETOPROTEIN (AFP) 112
11.3.2.1 IMMUNOASSAY REAGENTS & KITS 112
11.3.2.2 IMMUNOASSAY DEVICES 112
11.3.3 CARBOHYDRATE ANTIGEN 19-9 (CA 19-9) 112
11.3.3.1 IMMUNOASSAY REAGENTS & KITS 112
11.3.3.2 IMMUNOASSAY DEVICES 112
11.3.4 CARBOHYDRATE ANTIGEN 125 (CA 125) 113
11.3.4.1 IMMUNOASSAY REAGENTS & KITS 113
11.3.4.2 IMMUNOASSAY DEVICES 113
11.3.5 OTHERS 113
11.3.5.1 IMMUNOASSAY REAGENTS & KITS 113
11.3.5.2 IMMUNOASSAY DEVICES 113
11.4 ENDOCRINOLOGY 114
11.4.1 IMMUNOASSAY REAGENTS & KITS 114
11.4.2 IMMUNOASSAY DEVICES 114
11.5 BONE AND MINERAL DISORDERS 114
11.5.1 IMMUNOASSAY REAGENTS & KITS 114
11.5.2 IMMUNOASSAY DEVICES 114
11.6 CARDIOLOGY 115
11.6.1 IMMUNOASSAY REAGENTS & KITS 115
11.6.2 IMMUNOASSAY DEVICES 115
11.7 HEMATOLOGY AND BLOOD SCREENING 115
11.7.1 IMMUNOASSAY REAGENTS & KITS 115
11.7.2 IMMUNOASSAY DEVICES 115
11.8 AUTOIMMUNE DISORDERS 116
11.8.1 IMMUNOASSAY REAGENTS & KITS 116
11.8.2 IMMUNOASSAY DEVICES 116
11.9 TOXICOLOGY 116
11.9.1 IMMUNOASSAY REAGENTS & KITS 116
11.9.2 IMMUNOASSAY DEVICES 116
11.10 NEONATAL SCREENING 117
11.10.1 IMMUNOASSAY REAGENTS & KITS 117
11.10.2 IMMUNOASSAY DEVICES 117
11.11 ALLERGY DIAGNOSTICS 117
11.11.1 IMMUNOASSAY REAGENTS & KITS 117
11.11.2 IMMUNOASSAY DEVICES 117
11.12 GASTROLOGY 118
11.12.1 IMMUNOASSAY REAGENTS & KITS 118
11.12.2 IMMUNOASSAY DEVICES 118
11.13 OTHERS 118
11.13.1 IMMUNOASSAY REAGENTS & KITS 118
11.13.2 IMMUNOASSAY DEVICES 118
12 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER 119
12.1 OVERVIEW 120
12.2 HOSPITALS 123
12.2.1 PUBLIC 123
12.2.2 PRIVATE 123
12.2.3 TIER 3 124
12.2.4 TIER 2 124
12.2.5 TIER 1 124
12.3 CLINICAL LABORATORIES 124
12.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 124
12.5 BLOOD BANKS 124
12.6 RESEARCH AND ACADEMIC LABORATORIES 124
12.7 AMBULATORY CARE CENTERS 124
12.8 NURSING HOMES 124
12.9 HOME HEALTHCARE AGENCIES 125
12.10 OTHERS 125
13 CHINA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY LANDSCAPE 126
13.1 COMPANY SHARE ANALYSIS: CHINA 126
14 SWOT ANALYSIS 127
?
15 COMPANY PROFILES 128
15.1 F. HOFFMANN-LA ROCHE LTD 128
15.1.1 COMPANY SNAPSHOT 128
15.1.2 REVENUE ANALYSIS 128
15.1.3 PRODUCT PORTFOLIO 129
15.1.4 RECENT DEVELOPMENT/NEWS 131
15.2 SIEMENS 132
15.2.1 COMPANY SNAPSHOT 132
15.2.2 REVENUE ANALYSIS 132
15.2.3 PRODUCT PORTFOLIO 133
15.2.4 RECENT DEVELOPMENT 133
15.3 ABBOTT 134
15.3.1 COMPANY SNAPSHOT 134
15.3.2 REVENUE ANALYSIS 134
15.3.3 PRODUCT PORTFOLIO 135
15.3.4 RECENT DEVELOPMENT/NEWS 136
15.4 THERMO FISHER SCIENTIFIC INC. 137
15.4.1 COMPANY SNAPSHOT 137
15.4.2 REVENUE ANALYSIS 137
15.4.3 PRODUCT PORTFOLIO 138
15.4.4 RECENT DEVELOPMENT 139
15.5 QUIDELORTHO CORPORATION 140
15.5.1 COMPANY SNAPSHOT 140
15.5.2 REVENUE ANALYSIS 140
15.5.3 PRODUCT PORTFOLIO 141
15.5.4 RECENT DEVELOPMENT/NEWS 142
15.6 AGILENT TECHNOLOGIES, INC 143
15.6.1 COMPANY SNAPSHOT 143
15.6.2 REVENUE ANALYSIS 143
15.6.3 PRODUCT PORTFOLIO 144
15.6.4 RECENT DEVELOPMENT 144
15.7 BD 145
15.7.1 COMPANY SNAPSHOT 145
15.7.2 REVENUE ANALYSIS 145
15.7.3 PRODUCT PORTFOLIO 146
15.7.4 RECENT DEVELOPMENT/NEWS 146
?
15.8 BIO RAD LABORATORIES INC 147
15.8.1 COMPANY SNAPSHOT 147
15.8.2 REVENUE ANALYSIS 147
15.8.3 PRODUCT PORTFOLIO 148
15.8.4 RECENT DEVELOPMENT 149
15.9 BIO-TECHNE 150
15.9.1 COMPANY SNAPSHOT 150
15.9.2 REVENUE ANALYSIS 151
15.9.3 PRODUCT PORTFOLIO 151
15.9.4 RECENT DEVELOPMENT 152
15.10 BIOMERIEUX 153
15.10.1 COMPANY SNAPSHOT 153
15.10.2 REVENUE ANALYSIS 153
15.10.3 PRODUCT PORTFOLIO 154
15.10.4 RECENT DEVELOPMENT 154
15.11 DANAHER CORPORATION 155
15.11.1 COMPANY SNAPSHOT 155
15.11.2 REVENUE ANALYSIS 155
15.11.3 PRODUCT PORTFOLIO 156
15.11.4 RECENT DEVELOPMENT 156
15.12 DIASORIN 157
15.12.1 COMPANY SNAPSHOT 157
15.12.2 REVENUE ANALYSIS 157
15.12.3 PRODUCT PORTFOLIO 158
15.12.4 RECENT DEVELOPMENT/NEWS 158
15.13 HIPRO BIOTECHNOLOGY CO.LTD. 159
15.13.1 COMPANY SNAPSHOT 159
15.13.2 PRODUCT PORTFOLIO 159
15.13.3 RECENT DEVELOPMENT 159
15.14 QIAGEN 160
15.14.1 COMPANY SNAPSHOT 160
15.14.2 REVENUE ANALYSIS 160
15.14.3 PRODUCT PORTFOLIO 161
15.14.4 RECENT DEVELOPMENT 162
15.15 REVVITY 163
15.15.1 COMPANY SNAPSHOT 163
15.15.2 REVENUE ANALYSIS 163
15.15.3 PRODUCT PORTFOLIO 164
15.15.4 RECENT DEVELOPMENT 164
?
15.16 SD BIOSENSOR, INC. 165
15.16.1 COMPANY SNAPSHOT 165
15.16.2 REVENUE ANALYSIS 165
15.16.3 PRODUCT PORTFOLIO 166
15.16.4 RECENT DEVELOPMENT 166
15.17 SYSMEX CORPORATION 167
15.17.1 COMPANY SNAPSHOT 167
15.17.2 REVENUE ANALYSIS 167
15.17.3 PRODUCT PORTFOLIO 168
15.17.4 RECENT DEVELOPMENT 168
15.18 TOSOH BIOSCIENCE, INC 169
15.18.1 COMPANY SNAPSHOT 169
15.18.2 REVENUE ANALYSIS 169
15.18.3 PRODUCT PORTFOLIO 170
15.18.4 RECENT DEVELOPMENT 170
16 QUESTIONNAIRE 171
17 RELATED REPORTS 175
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security